Post-Grant Proceedings Are Important For Biosimilars
- Paul A. Calvo, Ph.D. and Eldora L. Ellison, Ph.D.
- IP Law360
In this IP Law360 article, Paul A. Calvo, Ph.D. and Eldora L. Ellison, Ph.D. discuss potential challenges facing biosimilar developers and the importance of post-grant patent challenges at the U.S. Patent and Trademark Office as a mechanism for obtaining early and fast patent certainty.
To read the full article, download the attached PDF.